Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

24 May, 2017, 07:00 ET OrphoMed Secures $39 Million Series A Financing Round

Company to accelerate clinical development of peripherally acting dimer ORP-101 for treatment of IBS-D OrphoMed, Inc., a clinical stage...


24 May, 2017, 06:30 ET Hebron Technology Co., Ltd. Wins Bid for a Project at Leading Pharmaceutical Company in Tianjin

Hebron Technology Co., Ltd. ("Hebron" or the "Company") (Nasdaq: HEBT), a developer, manufacturer and installer of valves and pipe fittings for use...


24 May, 2017, 06:15 ET How These Biotech Stocks are Faring? -- Idera Pharma, BioTime, RXi Pharma, and Tenax Therapeutics

This morning, Stock-Callers.com presents for scanning Idera Pharmaceuticals Inc. (NASDAQ: IDRA), BioTime Inc. (NYSE MKT: BTX), RXi Pharmaceuticals...


24 May, 2017, 03:09 ET Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres® Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows

Surgeons' blinded assessment of pre- and post-treatment CT scans of patients with previously unresectable colorectal cancer liver metastases...


24 May, 2017, 02:00 ET New On-Demand Targeted Next-Generation Sequencing Panels for Inherited Disease Research Deliver User Customization Without High Upfront Cost

Clinical researchers studying germline disorders now have access to an extension of the highly referenced, Ion AmpliSeq next-generation sequencing...


24 May, 2017, 02:00 ET Pruebas de secuenciación selectivas, de última generación y elaboradas bajo pedido sin grandes desembolsos iniciales

- La creación de pruebas de secuenciación selectivas, de última generación y elaboradas bajo pedido, destinadas a la investigación en enfermedades...


24 May, 2017, 02:00 ET I nuovi pannelli per sequenziamento di nuova generazione mirato su richiesta per la ricerca sulle malattie ereditarie offrono una personalizzazione per l'utente senza costi iniziali elevati

Thermo Fisher è in procinto di presentare la linea di prodotti su richiesta Ion AmpliSeq™ On-Demand di geni bersaglio pretestati e diverse altre...


24 May, 2017, 02:00 ET Norgine lanciert Ziverel® in Österreich, Belgien, Luxemburg und der Schweiz

ZIVEREL® dient dem Schutz und der Reparatur der Speiseröhrenschleimhaut Wie Norgine B.V. heute bekanntgab, ist ZIVEREL® ab sofort in...


24 May, 2017, 02:00 ET Norgine lanza Ziverel® en Austria, Bélgica, Luxemburgo y Suiza

ZIVEREL® está diseñado para proteger y reparar la mucosa esofágica Norgine B.V. ha anunciado hoy que ZIVEREL® está ya disponible en Austria,...


24 May, 2017, 02:00 ET Neue On-Demand-Panels zur gezielten Sequenzierung der nächsten Generation für die Erforschung von Erbkrankheiten bieten Nutzeranpassung ohne große Vorlaufkosten

Thermo Fisher stellt die AmpliSeq™ On-Demand-Produktreihe an vorgetesteten Gen-Targets und verschiedene weitere neue Ion Torrent NGS-Angebote auf...


24 May, 2017, 02:00 ET Norgine lance Ziverel® en Autriche, en Belgique, au Luxembourg et en Suisse

ZIVEREL® est conçu pour protéger et réparer la muqueuse œsophagienne Norgine B.V. a annoncé aujourd'hui que ZIVEREL® était désormais disponible...


24 May, 2017, 02:00 ET Nouveaux panneaux de séquençage de nouvelle génération ciblé sur demande pour la recherche sur les maladies héréditaires livrent une personnalisation pour l'utilisateur sans coût initial élevé

Thermo Fisher va présenter la gamme de produit Ion AmpliSeq™ On-Demand de cibles génétiques prétestées et plusieurs autres nouvelles offres Ion...


24 May, 2017, 01:37 ET Nordic Nanovector ASA - Results for First Quarter 2017

Nordic Nanovector ASA (OSE: NANO) announces results for the first quarter of 2017. A presentation by the company's senior management team will take...


24 May, 2017, 01:30 ET ThromboGenics to present THR-317 Pre-clinical Research Findings at the European Association for the Study of Diabetes, Eye Complications Study Group (EASDec) Meeting in Budapest, Hungary

ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel treatments for diabetic eye disease, announced today that it...


23 May, 2017, 21:30 ET Bone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.com

RnRMarketResearch.com adds "Bone Metastasis - Pipeline Review, H1 2017" therapeutic market research report of 100 pages with latest updates, data...


23 May, 2017, 18:09 ET Kristin Chenoweth Kicks Off 'Less Red, More You' Campaign To Launch RHOFADE™ (Oxymetazoline HCL) Cream, 1%

Allergan plc, (NYSE: AGN), a leading global pharmaceutical company, announced that Emmy® and Tony® award-winning actress and singer, Kristin...


23 May, 2017, 17:30 ET Allergan Announces Pricing of Public Offering of Senior Notes to Refinance Existing Debt

Allergan plc (NYSE: AGN) today announced that it has priced an offering of €2.7 billion aggregate principal amount of senior unsecured notes (the...


23 May, 2017, 17:00 ET First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, today confirmed enrollment of the first patient in the company's...


23 May, 2017, 16:14 ET FDA approves first cancer treatment for any solid tumor with a specific genetic feature

The U.S. Food and Drug Administration today granted accelerated approval to a treatment for patients whose cancers have a specific genetic feature...


23 May, 2017, 16:13 ET Global Dementia Partnering 2010 to 2017

Provides understanding and access to the dementia partnering deals and agreements entered into by the worlds leading healthcare...


23 May, 2017, 16:05 ET Tocagen Reports First Quarter 2017 Financial and Business Results

Tocagen Inc. (Nasdaq: TOCA), a clinical-stage, cancer-selective gene therapy company, today reported financial results for the first quarter ended...


23 May, 2017, 16:05 ET Sophiris Bio Provides Update on Phase 2b Study of Topsalysin in Localized Prostate Cancer

Sophiris Bio Inc. (NASDAQ: SPHS) (the "Company" or "Sophiris"), a late stage clinical biopharmaceutical company developing topsalysin...


23 May, 2017, 16:01 ET Ascendis Pharma A/S Reports First Quarter 2017 Financial Results

Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that utilizes its innovative TransCon technology to address significant unmet...


23 May, 2017, 16:01 ET Neurocrine Announces Phase II Results of VMAT2 Inhibitor INGREZZA® For Treatment of Tourette Syndrome

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) announced today that the initial Phase II Tourette syndrome T-Force GREEN study of...


23 May, 2017, 15:32 ET Global Drug Addiction Partnering 2010 to 2017

Provides understanding and access to the drug addiction partnering deals and agreements entered into by the worlds leading healthcare...